GnRHR ligands-stimulated Gαi activation inhibited cell proliferation of endometrial (HEC-1A and Ishikawa) and ovarian cancer cells (EFO-21 and EFO-27) through the suppression of mitogenic signal transduction [38–42]. The gene discussed is GNRHR; the disease is ovarian cancer.